The effect of vitamin D administration on bone and inflammatory indexes in hemodialysis patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190921044834N1

Enrollment

Registered

2019-12-04

Start date

2018-10-23

Completion date

Unknown

Last updated

2019-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemodialysis patients. ?????????? ????? ?????? ??????

Interventions

Intervention 1: Intervention group: allocation ratio into two groups to receive either 50,000 IU of cholecalciferol every week for 12 weeks. Intervention 2: Control group: allocation ratio into two gr

Eligibility

Sex/Gender

All

Age

15 Years to 70 Years

Inclusion criteria

Inclusion criteria: 15-70 years hemodialysis more than 3 month 3 times per week vitamin D less than 30 ml/ng

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Administration on bone. Timepoint: In the start of study? 84 days. Method of measurement: Factors of labratory.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamid tayyebi khosroshahi

Tabriz University of Medical Sciences

khosroshahih@TBZMED.ac.ir+98 41 3335 5921

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026